US2012296072A1PendingUtilityA1
N-terminally chemically modified protein compositions and methods
Est. expiryOct 12, 2014(expired)· nominal 20-yr term from priority
A61P 35/00A61P 9/10A61P 37/02A61P 31/12A61P 37/00A61P 7/00A61P 7/06A61P 3/06A61P 37/04A61P 25/00A61P 1/16A61K 47/60C07K 14/535C07K 14/56A61K 38/00
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are methods and compositions relating to the attachment of water soluble polymers to proteins. Provided are novel methods for N-terminally modifying proteins or analogs thereof, and resultant compositions, including novel N-terminally chemically modified G-CSF compositions and related methods of preparation. Also provided is chemically modified consensus interferon.
Claims
exact text as granted — not AI-modified1 - 11 . (canceled)
12 . A method for attaching a water soluble polymer to a protein or analog thereof, wherein said water soluble polymer has a single reactive aldehyde group, said method comprising:
(a) reacting a protein moiety with a water soluble polymer moiety under reducing alkylation conditions, at a pH sufficiently acidic to selectively activate the α-amino group at the amino terminus of said protein moiety so that said water soluble polymer selectively attaches to said α-amino group; and (b) obtaining the reaction product and (c) optionally, separating the reaction products from unreacted moieties.
13 . A method of claim 12 wherein said polymer is pharmaceutically acceptable.
14 . A method of claim 12 wherein said water soluble polymer is selected from the group consisting of dextran, poly (n-vinyl pyurrolidone), polyethylene glycols, propropylene glycol homopolymers, prolypropylene oxide/ethylene oxide co-polymers, polyoxyethylated polyols and polyvinyl alcohols.
15 . A method of claim 14 wherein said polymer is polyethylene glycol.
16 . A method of claim 12 wherein said reducing alkylation reaction involves the use of a reducing agent selected from sodium borohydride, sodium cyanoborohydride, dimethylamine borate, timethylamine borate and pyridine borate.
17 - 38 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.